Compelling Safety Profile of BVX001 | 13-Jun-2024 | 07:00 | RNS |
Innovate UK Grant Award to Accelerate ADC Pipeline | 06-Jun-2024 | 07:00 | RNS |
BiVictriX – Full Year Results 2023 | 31-May-2024 | 08:44 | RNS |
Orphan Drug Designation & FDA INTERACT Meeting | 17-Apr-2024 | 07:00 | RNS |
Grant of Options – PDMR/Direc... | 28-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Jan-2024 | 12:30 | RNS |
Holding(s) in Company | 04-Jan-2024 | 12:30 | RNS |
BiVictriX Hosts Inaugural Roundtable Discussion | 04-Jan-2024 | 07:00 | RNS |
Board Change | 05-Dec-2023 | 11:08 | RNS |
Pipeline update on BVX002 | 30-Nov-2023 | 07:00 | RNS |
Holding(s) in Company | 22-Nov-2023 | 17:14 | RNS |
Patent Granted in Japan | 15-Nov-2023 | 07:00 | RNS |
Extended Survival Rates Reported with BVX001 | 12-Oct-2023 | 07:00 | RNS |
Appointment of Adrian Howd as CFO and CBO | 03-Oct-2023 | 07:00 | RNS |
Interim Results | 19-Sep-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 12.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 15.90 |
52 Week Low | 10.00 |
Volume | 21,491 |
Shares Issued | 82.53m |
Market Cap | £10.11m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:35 | 33 @ 13.00p |
14:00 | 245 @ 13.00p |
14:00 | 245 @ 13.00p |
11:50 | 35 @ 13.00p |
10:38 | 720 @ 12.22p |
You are here: research